Organon
POSTED
06-29-23
Organon Publishes 2022 ESG Report Showcasing Progress Toward Global Sustainability Goals
Organon (NYSE: OGN), a global healthcare company focused on women’s health, today released its 2022-2023 Environmental, Social, and Governance (ESG) Report.
POSTED
11-14-22
Organon Announces Formal Commitment to FP2030 To Help Prevent 120 Million Unintended Pregnancies in Low- and Middle-Income Countries Around the World
Organon announces company’s formal commitment to FP2030 at International Conference on Family Planning in Pattaya City, Thailand
